Publications & Research

Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers

This study found that ultrasonography has yielded savings of more than $4,000 per patient by reducing the occurrence of unnecessary, invasive breast cancer procedures.

Click here to view the full study.

  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More